Romosozumab 3 vs 12: 3 months of romosozumab | Hormone Insight Podcast
Is 3 months of romosozumab noninferior to 12 months for increasing hip BMD in postmenopausal osteoporosis?In postmenopausal women at high fracture ris...
Hormone Insight
Share:
Listens: 1155
About
Discuss Diabetes and Endocrinology studies in a simplified manner. Expand your knowledge in Diabetes and Endocrinology.
CHIRACIC: Surgery for mild cortisol excess? | Hormone Insight Podcast
Can surgery treat arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion?In patients with hyp...
TRAVERSE: Is testosterone heart-safe? | Hormone Insight Podcast
Was testosterone replacement non-inferior to placebo for cardiovascular safety in men with hypogonadism and high cardiovascular risk?In TRAVERSE, test...
Statin side effects: Which ones are real? | Hormone Insight Podcast
Which statin side effects are supported by blinded trials?Blinded-trial evidence supported increased liver-test abnormalities but did not show excess...
CLEAR Outcomes: Statin-intolerant patients | Hormone Insight Podcast
Does bempedoic acid reduce cardiovascular events in statin-intolerant patients?In CLEAR Outcomes, bempedoic acid lowered LDL cholesterol and reduced m...
LT4 withdrawal: Can we stop levothyroxine? | Hormone Insight Podcast
Can levothyroxine be discontinued in older adults with subclinical hypothyroidism?In a pilot randomised trial, stopping low-dose levothyroxine did not...
ORBIT: IL-17 for thyroid eye disease? | Hormone Insight Podcast
Is secukinumab effective for active, moderate-to-severe Graves orbitopathy?In a randomised trial, secukinumab did not improve clinical response compar...
GRASS: Selenium in Graves' | Hormone Insight Podcast
Does selenium supplementation benefit people with newly diagnosed Graves' hyperthyroidism?In the GRASS randomised trial, selenium did not improve remi...
ESTIMABL2: No radioiodine at 5 years | Hormone Insight Podcast
What happens at 5 years of follow-up with thyroidectomy without radioiodine in patients with low-risk thyroid cancer?In patients with low-risk differe...
IoN: Skip radioiodine? | Hormone Insight Podcast
After thyroidectomy for low-risk differentiated thyroid cancer, is omission of postoperative radioiodine non-inferior to ablation?In the IoN randomise...